SureTrader Nadex Advertisement SureTrader
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: lucky,mydog, Penny Traders Club, bz777, HighYieldStocks
Search This Board: 
Last Post: 4/23/2017 1:03:30 AM - Followers: 392 - Board type: Free - Posts Today: 10



Arrayit (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.


- Powerful Science for Life™



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection


About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ARYC News: Current Report Filing (8-k) 12/05/2016 04:31:06 PM
ARYC News: Current Report Filing (8-k) 12/05/2016 03:16:26 PM
#43578  Sticky Note SKULL AND CROSSBONES FOR ARYC. lucky,mydog 04/15/17 01:08:12 PM
#43132  Sticky Note I am here at arrayit office . ANRK 04/10/17 01:52:45 PM
#42929  Sticky Note ***Ten Reasons To Invest in Arrayit Corporation (ARYC)*** Penny Traders Club 04/01/17 11:54:57 AM
#41045  Sticky Note Here are the details and DD updates ChartAnalyst 02/08/17 10:32:34 AM
#44789   Respectfully, and no one here needs any help havnagoodtime 04/23/17 12:53:40 AM
#44788   TCA global a toxic financier/lender for penny stock's.. stock1ace1 04/23/17 12:29:24 AM
#44787   Please do your due diligence on this Silicon UndervaluedStocks 04/23/17 12:14:26 AM
#44786   Not spam just facts on Aryc, no false stock1ace1 04/23/17 12:13:04 AM
#44785   basher stock1ace1 needs to get his spam posts UndervaluedStocks 04/23/17 12:08:14 AM
#44784   haven't filed there 10q since (2015) Real DD (Facts) #ARYC http://www.otcmark stock1ace1 04/23/17 12:05:22 AM
#44783   ($-4,026,297) Net Loss from latest 10q Real DD stock1ace1 04/23/17 12:04:32 AM
#44782   ($0) Cash On Hand from latest 10q Real stock1ace1 04/23/17 12:03:40 AM
#44781   ($-32,029,372) accumulated deficit ! Real DD (Facts) #ARYC http://www.otcmark stock1ace1 04/23/17 12:02:57 AM
#44780   I agree and I'm still accumulating for a Meq 04/22/17 11:51:06 PM
#44779   With this entry point our highs will highly WallStreetMyWay 04/22/17 11:19:45 PM
#44778   Based on morningstar web link I just posted, Ken1998 04/22/17 10:53:14 PM
#44777   The price action is developing in key support. WallStreetMyWay 04/22/17 10:51:20 PM
#44776   I understands the long term value of a WallStreetMyWay 04/22/17 10:48:19 PM
#44774   Morninstar says ARYC is currently undervalued, Check website Ken1998 04/22/17 10:42:13 PM
#44773   WallStreet this could be the diamond in the Meq 04/22/17 10:34:41 PM
#44772   Lots of luck to you- right place at bz777 04/22/17 10:30:57 PM
#44771   Thanks for all the reading material. I'm impressed havnagoodtime 04/22/17 10:28:54 PM
#44767   Aryc is a company with about $3 target Ken1998 04/22/17 08:31:52 PM
#44765   I agree the actuality looks good. Nice balance WallStreetMyWay 04/22/17 06:51:05 PM
#44764   Once people see the fins, ARYC will be glory2000 04/22/17 06:02:27 PM
#44763   You have to admit though, the chart looks hawt!!!! Backstabbed 04/22/17 04:23:15 PM
#44761   Monday I'm in in4damoney 04/22/17 03:33:21 PM
#44760   $ARYC Arrayit reports $6MM business development proposal from HotStockAlerts 04/22/17 02:41:37 PM
#44759   $ARYC - Arrayit reports Agilent microarray request from HotStockAlerts 04/22/17 02:40:56 PM
#44758   $ARYC - Arrayit 260K twitter followers compare favorably HotStockAlerts 04/22/17 02:40:20 PM
#44757   $ARYC - Arrayit 260K twitter followers compare favorably HotStockAlerts 04/22/17 02:39:50 PM
#44756   $ARYC - Arrayit reports microarray technology sale to HotStockAlerts 04/22/17 02:39:33 PM
#44755   $ARYC - Arrayit provides technical support to top HotStockAlerts 04/22/17 02:39:18 PM
#44754   $ARYC - Arrayit reports microarray technology sale to HotStockAlerts 04/22/17 02:39:05 PM
#44753   $ARYC - Arrayit reports microarray technology sale to HotStockAlerts 04/22/17 02:38:53 PM
#44752   Thanks. headnorthw 04/22/17 02:20:26 PM
#44751   Welcome to the board Elvis :) UndervaluedStocks 04/22/17 01:58:34 PM
#44750   Thanks! Checked it out...I picked up some Friday. ElvisFunk 04/22/17 01:28:07 PM
#44748   Arrayit ships $38,485 microarray platform to top Korean UndervaluedStocks 04/22/17 01:02:34 PM
#44747   Going to be huge Q1 numbers coming imo.. bz777 04/22/17 12:53:05 PM
#44746   google scholar search for arrayit microarray: bz777 04/22/17 12:52:28 PM
#44745 bz777 04/22/17 12:51:32 PM
#44744   Home > VWR Catalog > Microarray Instruments bz777 04/22/17 12:50:36 PM
#44743   real biotech co here with indemand product: bz777 04/22/17 12:49:40 PM
#44742   Time is running short to add shares here bz777 04/22/17 12:48:30 PM
#44741   And notice any familiar names in the references bz777 04/22/17 12:47:40 PM
#44740   arrayit specialty: bz777 04/22/17 12:46:51 PM
#44739   Reading for all new shareholders: bz777 04/22/17 12:45:29 PM
#44738   weekly: bz777 04/22/17 12:44:46 PM
#44737 bz777 04/22/17 12:43:23 PM
#44736   accumulation: bz777 04/22/17 12:42:57 PM
#44735 bz777 04/22/17 12:40:45 PM
#44734   should be a good Monday that's for sure! bz777 04/22/17 12:38:34 PM
#44733   Welcome to the board sir. Here is some UndervaluedStocks 04/22/17 12:36:35 PM